MedPath

Cipla USA, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.ciplausa.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

FDA:7

Drug Approvals

Phytonadione

Approval Date
Nov 1, 2023
FDA

Bupropion Hydrochloride

Approval Date
Oct 19, 2023
FDA

OSELTAMIVIR PHOSPHATE

Approval Date
May 2, 2023
FDA

DILTIAZEM HYDROCHLORIDE

Approval Date
May 1, 2023
FDA

Lurasidone Hydrochloride

Approval Date
Jan 19, 2023
FDA

Pregabalin

Approval Date
Jan 18, 2023
FDA

VIGABATRIN

Approval Date
May 10, 2022
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.